nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—ABCB1—melanoma	0.253	1	CbGaD
Domperidone—CYP1A2—Carmustine—melanoma	0.102	0.156	CbGbCtD
Domperidone—CYP1A2—Vemurafenib—melanoma	0.0806	0.124	CbGbCtD
Domperidone—CYP3A4—Temozolomide—melanoma	0.077	0.118	CbGbCtD
Domperidone—CYP2D6—Vemurafenib—melanoma	0.0664	0.102	CbGbCtD
Domperidone—CYP1A2—Dacarbazine—melanoma	0.0617	0.0948	CbGbCtD
Domperidone—CYP3A7—Docetaxel—melanoma	0.0495	0.076	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0495	0.076	CbGbCtD
Domperidone—ABCB1—Dactinomycin—melanoma	0.0468	0.0719	CbGbCtD
Domperidone—CYP3A4—Vemurafenib—melanoma	0.0422	0.0648	CbGbCtD
Domperidone—CYP3A5—Docetaxel—melanoma	0.0371	0.057	CbGbCtD
Domperidone—ABCB1—Docetaxel—melanoma	0.0242	0.0371	CbGbCtD
Domperidone—CYP3A4—Docetaxel—melanoma	0.0145	0.0222	CbGbCtD
Domperidone—Menstruation irregular—Docetaxel—melanoma	0.001	0.0315	CcSEcCtD
Domperidone—Breast pain—Temozolomide—melanoma	0.000959	0.0301	CcSEcCtD
Domperidone—Heartburn—Docetaxel—melanoma	0.000808	0.0254	CcSEcCtD
Domperidone—Disorientation—Bleomycin—melanoma	0.000805	0.0253	CcSEcCtD
Domperidone—Gynaecomastia—Carmustine—melanoma	0.000774	0.0243	CcSEcCtD
Domperidone—Lethargy—Dactinomycin—melanoma	0.000685	0.0215	CcSEcCtD
Domperidone—Hot flush—Temozolomide—melanoma	0.000649	0.0204	CcSEcCtD
Domperidone—Menopausal symptoms—Temozolomide—melanoma	0.000643	0.0202	CcSEcCtD
Domperidone—Thirst—Temozolomide—melanoma	0.000638	0.02	CcSEcCtD
Domperidone—Hypotension—Vemurafenib—melanoma	0.000546	0.0171	CcSEcCtD
Domperidone—Stomatitis—Bleomycin—melanoma	0.000541	0.017	CcSEcCtD
Domperidone—Stomatitis—Dactinomycin—melanoma	0.000504	0.0158	CcSEcCtD
Domperidone—Constipation—Vemurafenib—melanoma	0.000499	0.0157	CcSEcCtD
Domperidone—Dysuria—Temozolomide—melanoma	0.000491	0.0154	CcSEcCtD
Domperidone—Pollakiuria—Temozolomide—melanoma	0.000485	0.0152	CcSEcCtD
Domperidone—Stomatitis—Carmustine—melanoma	0.000472	0.0148	CcSEcCtD
Domperidone—Stomatitis—Temozolomide—melanoma	0.000456	0.0143	CcSEcCtD
Domperidone—Hot flush—Docetaxel—melanoma	0.000432	0.0135	CcSEcCtD
Domperidone—Menopausal symptoms—Docetaxel—melanoma	0.000428	0.0134	CcSEcCtD
Domperidone—Asthenia—Vemurafenib—melanoma	0.000419	0.0132	CcSEcCtD
Domperidone—Pruritus—Vemurafenib—melanoma	0.000413	0.013	CcSEcCtD
Domperidone—Lethargy—Docetaxel—melanoma	0.000412	0.0129	CcSEcCtD
Domperidone—Diarrhoea—Vemurafenib—melanoma	0.0004	0.0125	CcSEcCtD
Domperidone—Migraine—Docetaxel—melanoma	0.000397	0.0125	CcSEcCtD
Domperidone—Arrhythmia—Carmustine—melanoma	0.000388	0.0122	CcSEcCtD
Domperidone—Dizziness—Vemurafenib—melanoma	0.000386	0.0121	CcSEcCtD
Domperidone—Vomiting—Vemurafenib—melanoma	0.000371	0.0117	CcSEcCtD
Domperidone—Rash—Vemurafenib—melanoma	0.000368	0.0116	CcSEcCtD
Domperidone—Dermatitis—Vemurafenib—melanoma	0.000368	0.0115	CcSEcCtD
Domperidone—Headache—Vemurafenib—melanoma	0.000366	0.0115	CcSEcCtD
Domperidone—Oedema—Bleomycin—melanoma	0.000354	0.0111	CcSEcCtD
Domperidone—Nausea—Vemurafenib—melanoma	0.000347	0.0109	CcSEcCtD
Domperidone—Hypotension—Bleomycin—melanoma	0.000331	0.0104	CcSEcCtD
Domperidone—Oedema—Dactinomycin—melanoma	0.00033	0.0104	CcSEcCtD
Domperidone—Palpitations—Temozolomide—melanoma	0.000323	0.0101	CcSEcCtD
Domperidone—Oedema—Carmustine—melanoma	0.000309	0.00969	CcSEcCtD
Domperidone—Dry mouth—Temozolomide—melanoma	0.000304	0.00956	CcSEcCtD
Domperidone—Stomatitis—Docetaxel—melanoma	0.000303	0.00952	CcSEcCtD
Domperidone—Conjunctivitis—Docetaxel—melanoma	0.000302	0.00949	CcSEcCtD
Domperidone—Oedema—Temozolomide—melanoma	0.000298	0.00937	CcSEcCtD
Domperidone—Hypotension—Carmustine—melanoma	0.000289	0.00906	CcSEcCtD
Domperidone—Urticaria—Bleomycin—melanoma	0.000281	0.00882	CcSEcCtD
Domperidone—Insomnia—Carmustine—melanoma	0.000279	0.00877	CcSEcCtD
Domperidone—Somnolence—Carmustine—melanoma	0.000275	0.00862	CcSEcCtD
Domperidone—Insomnia—Temozolomide—melanoma	0.00027	0.00847	CcSEcCtD
Domperidone—Somnolence—Temozolomide—melanoma	0.000265	0.00833	CcSEcCtD
Domperidone—Constipation—Carmustine—melanoma	0.000264	0.00829	CcSEcCtD
Domperidone—Dyspepsia—Temozolomide—melanoma	0.000263	0.00825	CcSEcCtD
Domperidone—Abdominal pain—Dactinomycin—melanoma	0.000261	0.00819	CcSEcCtD
Domperidone—Constipation—Temozolomide—melanoma	0.000255	0.00801	CcSEcCtD
Domperidone—Asthenia—Bleomycin—melanoma	0.000254	0.00797	CcSEcCtD
Domperidone—Pruritus—Bleomycin—melanoma	0.00025	0.00786	CcSEcCtD
Domperidone—Arrhythmia—Docetaxel—melanoma	0.00025	0.00783	CcSEcCtD
Domperidone—Abdominal pain—Carmustine—melanoma	0.000244	0.00766	CcSEcCtD
Domperidone—Urticaria—Temozolomide—melanoma	0.000237	0.00744	CcSEcCtD
Domperidone—Asthenia—Dactinomycin—melanoma	0.000237	0.00743	CcSEcCtD
Domperidone—Abdominal pain—Temozolomide—melanoma	0.000236	0.00741	CcSEcCtD
Domperidone—Muscle spasms—Docetaxel—melanoma	0.000234	0.00734	CcSEcCtD
Domperidone—Diarrhoea—Dactinomycin—melanoma	0.000226	0.00709	CcSEcCtD
Domperidone—Vomiting—Bleomycin—melanoma	0.000225	0.00706	CcSEcCtD
Domperidone—Rash—Bleomycin—melanoma	0.000223	0.007	CcSEcCtD
Domperidone—Dermatitis—Bleomycin—melanoma	0.000223	0.007	CcSEcCtD
Domperidone—Asthenia—Carmustine—melanoma	0.000222	0.00695	CcSEcCtD
Domperidone—Palpitations—Docetaxel—melanoma	0.000215	0.00675	CcSEcCtD
Domperidone—Asthenia—Temozolomide—melanoma	0.000214	0.00672	CcSEcCtD
Domperidone—Diarrhoea—Carmustine—melanoma	0.000211	0.00663	CcSEcCtD
Domperidone—Pruritus—Temozolomide—melanoma	0.000211	0.00663	CcSEcCtD
Domperidone—Nausea—Bleomycin—melanoma	0.00021	0.0066	CcSEcCtD
Domperidone—Vomiting—Dactinomycin—melanoma	0.00021	0.00659	CcSEcCtD
Domperidone—Rash—Dactinomycin—melanoma	0.000208	0.00653	CcSEcCtD
Domperidone—Dizziness—Carmustine—melanoma	0.000204	0.00641	CcSEcCtD
Domperidone—Diarrhoea—Temozolomide—melanoma	0.000204	0.00641	CcSEcCtD
Domperidone—Dry mouth—Docetaxel—melanoma	0.000202	0.00636	CcSEcCtD
Domperidone—Oedema—Docetaxel—melanoma	0.000198	0.00623	CcSEcCtD
Domperidone—Dizziness—Temozolomide—melanoma	0.000197	0.00619	CcSEcCtD
Domperidone—Vomiting—Carmustine—melanoma	0.000196	0.00616	CcSEcCtD
Domperidone—Nausea—Dactinomycin—melanoma	0.000196	0.00615	CcSEcCtD
Domperidone—Rash—Carmustine—melanoma	0.000195	0.00611	CcSEcCtD
Domperidone—Dermatitis—Carmustine—melanoma	0.000195	0.00611	CcSEcCtD
Domperidone—Headache—Carmustine—melanoma	0.000193	0.00607	CcSEcCtD
Domperidone—Vomiting—Temozolomide—melanoma	0.00019	0.00596	CcSEcCtD
Domperidone—Rash—Temozolomide—melanoma	0.000188	0.00591	CcSEcCtD
Domperidone—Dermatitis—Temozolomide—melanoma	0.000188	0.0059	CcSEcCtD
Domperidone—Headache—Temozolomide—melanoma	0.000187	0.00587	CcSEcCtD
Domperidone—Hypotension—Docetaxel—melanoma	0.000185	0.00582	CcSEcCtD
Domperidone—Nausea—Carmustine—melanoma	0.000183	0.00576	CcSEcCtD
Domperidone—Insomnia—Docetaxel—melanoma	0.000179	0.00563	CcSEcCtD
Domperidone—Nausea—Temozolomide—melanoma	0.000177	0.00556	CcSEcCtD
Domperidone—Somnolence—Docetaxel—melanoma	0.000176	0.00554	CcSEcCtD
Domperidone—Dyspepsia—Docetaxel—melanoma	0.000175	0.00548	CcSEcCtD
Domperidone—Constipation—Docetaxel—melanoma	0.00017	0.00533	CcSEcCtD
Domperidone—Abdominal pain—Docetaxel—melanoma	0.000157	0.00492	CcSEcCtD
Domperidone—Asthenia—Docetaxel—melanoma	0.000142	0.00447	CcSEcCtD
Domperidone—Pruritus—Docetaxel—melanoma	0.00014	0.00441	CcSEcCtD
Domperidone—Diarrhoea—Docetaxel—melanoma	0.000136	0.00426	CcSEcCtD
Domperidone—Dizziness—Docetaxel—melanoma	0.000131	0.00412	CcSEcCtD
Domperidone—Vomiting—Docetaxel—melanoma	0.000126	0.00396	CcSEcCtD
Domperidone—Rash—Docetaxel—melanoma	0.000125	0.00393	CcSEcCtD
Domperidone—Dermatitis—Docetaxel—melanoma	0.000125	0.00392	CcSEcCtD
Domperidone—Headache—Docetaxel—melanoma	0.000124	0.0039	CcSEcCtD
Domperidone—Nausea—Docetaxel—melanoma	0.000118	0.0037	CcSEcCtD
Domperidone—CYP1A2—Metabolism—VCAN—melanoma	9.83e-06	0.000156	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GNA11—melanoma	9.81e-06	0.000155	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP17A1—melanoma	9.79e-06	0.000155	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ABCB1—melanoma	9.77e-06	0.000155	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CD86—melanoma	9.63e-06	0.000152	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—CXCL8—melanoma	9.63e-06	0.000152	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.62e-06	0.000152	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—FASN—melanoma	9.6e-06	0.000152	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—FN1—melanoma	9.58e-06	0.000152	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EDN1—melanoma	9.56e-06	0.000151	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ABCB1—melanoma	9.55e-06	0.000151	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CG—melanoma	9.52e-06	0.000151	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—SLC5A5—melanoma	9.45e-06	0.00015	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NOTCH1—melanoma	9.37e-06	0.000148	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGF1—melanoma	9.34e-06	0.000148	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CSF2—melanoma	9.34e-06	0.000148	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.31e-06	0.000147	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GNA11—melanoma	9.25e-06	0.000146	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL2—melanoma	9.2e-06	0.000146	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PPARG—melanoma	9.19e-06	0.000145	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CD80—melanoma	9.18e-06	0.000145	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—APC—melanoma	9.17e-06	0.000145	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CG—melanoma	9.17e-06	0.000145	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KIT—melanoma	9.17e-06	0.000145	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—NRAS—melanoma	9.17e-06	0.000145	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—E2F1—melanoma	9.14e-06	0.000145	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GNAQ—melanoma	9.12e-06	0.000144	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CD44—melanoma	9.12e-06	0.000144	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CB—melanoma	9.1e-06	0.000144	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGF—melanoma	9.06e-06	0.000143	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—FASN—melanoma	9.05e-06	0.000143	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PDGFRA—melanoma	9.05e-06	0.000143	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PRKCA—melanoma	8.99e-06	0.000142	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.98e-06	0.000142	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ITGB3—melanoma	8.95e-06	0.000142	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PRKCA—melanoma	8.95e-06	0.000142	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ERCC2—melanoma	8.91e-06	0.000141	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SLC5A5—melanoma	8.9e-06	0.000141	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.86e-06	0.00014	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PRKCA—melanoma	8.79e-06	0.000139	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SPP1—melanoma	8.78e-06	0.000139	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—MAPK3—melanoma	8.78e-06	0.000139	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAP2K2—melanoma	8.75e-06	0.000139	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP1B1—melanoma	8.75e-06	0.000138	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—CXCL8—melanoma	8.74e-06	0.000138	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ERCC2—melanoma	8.71e-06	0.000138	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—BRAF—melanoma	8.62e-06	0.000136	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GNAQ—melanoma	8.6e-06	0.000136	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CD44—melanoma	8.6e-06	0.000136	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PLA2G6—melanoma	8.45e-06	0.000134	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IGF1—melanoma	8.39e-06	0.000133	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CD—melanoma	8.37e-06	0.000132	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—melanoma	8.36e-06	0.000132	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—MAPK1—melanoma	8.35e-06	0.000132	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—EGFR—melanoma	8.35e-06	0.000132	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TERT—melanoma	8.32e-06	0.000132	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RAC1—melanoma	8.3e-06	0.000131	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP17A1—melanoma	8.3e-06	0.000131	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ABCB1—melanoma	8.27e-06	0.000131	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ALB—melanoma	8.26e-06	0.000131	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1B1—melanoma	8.24e-06	0.00013	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.18e-06	0.000129	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAP2K1—melanoma	8.11e-06	0.000128	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	8.08e-06	0.000128	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CD—melanoma	8.06e-06	0.000128	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—PIK3CA—melanoma	7.98e-06	0.000126	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HIF1A—melanoma	7.96e-06	0.000126	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—KRAS—melanoma	7.89e-06	0.000125	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GNA11—melanoma	7.83e-06	0.000124	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—FGF2—melanoma	7.72e-06	0.000122	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—FASN—melanoma	7.67e-06	0.000121	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KDR—melanoma	7.61e-06	0.00012	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PRKCA—melanoma	7.61e-06	0.00012	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—VCAN—melanoma	7.59e-06	0.00012	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ERCC2—melanoma	7.55e-06	0.000119	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC5A5—melanoma	7.54e-06	0.000119	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FN1—melanoma	7.33e-06	0.000116	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CB—melanoma	7.29e-06	0.000115	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GNAQ—melanoma	7.28e-06	0.000115	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CD44—melanoma	7.28e-06	0.000115	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CA—melanoma	7.25e-06	0.000115	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—melanoma	7.23e-06	0.000114	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MDM2—melanoma	7.22e-06	0.000114	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOTCH1—melanoma	7.17e-06	0.000114	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.13e-06	0.000113	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ERBB2—melanoma	7.12e-06	0.000113	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.07e-06	0.000112	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CG—melanoma	7.04e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CD80—melanoma	7.03e-06	0.000111	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CB—melanoma	7.02e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CG—melanoma	7.01e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APC—melanoma	7.01e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KIT—melanoma	7.01e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—NRAS—melanoma	7.01e-06	0.000111	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP1B1—melanoma	6.98e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGF—melanoma	6.93e-06	0.00011	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CG—melanoma	6.88e-06	0.000109	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PPARG—melanoma	6.79e-06	0.000108	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ABCB1—melanoma	6.79e-06	0.000107	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CXCL8—melanoma	6.75e-06	0.000107	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK3—melanoma	6.72e-06	0.000106	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—HRAS—melanoma	6.71e-06	0.000106	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPARG—melanoma	6.64e-06	0.000105	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PRKCA—melanoma	6.63e-06	0.000105	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BRAF—melanoma	6.59e-06	0.000104	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1B—melanoma	6.59e-06	0.000104	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ERCC2—melanoma	6.57e-06	0.000104	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT1—melanoma	6.52e-06	0.000103	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CASP3—melanoma	6.46e-06	0.000102	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—melanoma	6.45e-06	0.000102	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF1—melanoma	6.42e-06	0.000102	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—melanoma	6.42e-06	0.000102	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP17A1—melanoma	6.4e-06	0.000101	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK1—melanoma	6.39e-06	0.000101	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—EGFR—melanoma	6.39e-06	0.000101	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTEN—melanoma	6.3e-06	9.97e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCND1—melanoma	6.29e-06	9.95e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.25e-06	9.89e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PRKCA—melanoma	6.25e-06	9.89e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CTNNB1—melanoma	6.23e-06	9.85e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAP2K1—melanoma	6.21e-06	9.82e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ERCC2—melanoma	6.2e-06	9.8e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CD—melanoma	6.19e-06	9.79e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CD—melanoma	6.17e-06	9.76e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.16e-06	9.75e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ALB—melanoma	6.11e-06	9.67e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CA—melanoma	6.11e-06	9.67e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MMP9—melanoma	6.1e-06	9.66e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1A—melanoma	6.08e-06	9.63e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTEN—melanoma	6.07e-06	9.6e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CD—melanoma	6.05e-06	9.57e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GNA11—melanoma	6.05e-06	9.57e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NFKB1—melanoma	6.04e-06	9.56e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—KRAS—melanoma	6.04e-06	9.55e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ALB—melanoma	5.97e-06	9.45e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CG—melanoma	5.96e-06	9.43e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT1—melanoma	5.92e-06	9.37e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—FASN—melanoma	5.92e-06	9.36e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGF2—melanoma	5.9e-06	9.34e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC5A5—melanoma	5.82e-06	9.21e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARG—melanoma	5.75e-06	9.1e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ABCB1—melanoma	5.75e-06	9.1e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GNAQ—melanoma	5.62e-06	8.9e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CD44—melanoma	5.62e-06	8.9e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CA—melanoma	5.55e-06	8.78e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MDM2—melanoma	5.52e-06	8.74e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—melanoma	5.48e-06	8.68e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ERBB2—melanoma	5.45e-06	8.62e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—melanoma	5.43e-06	8.59e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NRAS—melanoma	5.41e-06	8.57e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CB—melanoma	5.39e-06	8.54e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1B1—melanoma	5.39e-06	8.53e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CB—melanoma	5.37e-06	8.51e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—melanoma	5.35e-06	8.46e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PRKCA—melanoma	5.29e-06	8.37e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CB—melanoma	5.27e-06	8.34e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ERCC2—melanoma	5.25e-06	8.31e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CD—melanoma	5.24e-06	8.29e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—melanoma	5.22e-06	8.27e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CG—melanoma	5.19e-06	8.22e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK3—melanoma	5.19e-06	8.21e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ALB—melanoma	5.17e-06	8.19e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CXCL8—melanoma	5.16e-06	8.17e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—HRAS—melanoma	5.13e-06	8.12e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1B—melanoma	5.04e-06	7.98e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—melanoma	5.04e-06	7.98e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARG—melanoma	5.01e-06	7.93e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT1—melanoma	4.99e-06	7.9e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CASP3—melanoma	4.94e-06	7.82e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—melanoma	4.94e-06	7.81e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK1—melanoma	4.93e-06	7.81e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EGFR—melanoma	4.93e-06	7.81e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—melanoma	4.91e-06	7.77e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CG—melanoma	4.89e-06	7.74e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCND1—melanoma	4.81e-06	7.61e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CTNNB1—melanoma	4.76e-06	7.54e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARG—melanoma	4.72e-06	7.47e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MMP9—melanoma	4.67e-06	7.39e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTEN—melanoma	4.66e-06	7.38e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KRAS—melanoma	4.66e-06	7.38e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1A—melanoma	4.65e-06	7.37e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTEN—melanoma	4.64e-06	7.35e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NFKB1—melanoma	4.62e-06	7.31e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CB—melanoma	4.57e-06	7.23e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CD—melanoma	4.56e-06	7.22e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTEN—melanoma	4.56e-06	7.21e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT1—melanoma	4.53e-06	7.17e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—melanoma	4.53e-06	7.16e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ALB—melanoma	4.51e-06	7.13e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CA—melanoma	4.45e-06	7.04e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCB1—melanoma	4.44e-06	7.02e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.35e-06	6.88e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CD—melanoma	4.3e-06	6.81e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CA—melanoma	4.28e-06	6.78e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ALB—melanoma	4.25e-06	6.72e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—melanoma	4.19e-06	6.64e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—melanoma	4.15e-06	6.57e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CG—melanoma	4.15e-06	6.56e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NRAS—melanoma	4.14e-06	6.56e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—melanoma	4.14e-06	6.56e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PRKCA—melanoma	4.08e-06	6.46e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ERCC2—melanoma	4.05e-06	6.41e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARG—melanoma	4e-06	6.33e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CB—melanoma	3.98e-06	6.3e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK3—melanoma	3.97e-06	6.28e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HRAS—melanoma	3.96e-06	6.27e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTEN—melanoma	3.95e-06	6.25e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—melanoma	3.94e-06	6.24e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—melanoma	3.86e-06	6.11e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—melanoma	3.79e-06	6e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK1—melanoma	3.78e-06	5.98e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EGFR—melanoma	3.77e-06	5.97e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CB—melanoma	3.75e-06	5.93e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—melanoma	3.71e-06	5.88e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CD—melanoma	3.64e-06	5.77e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—AKT1—melanoma	3.63e-06	5.75e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALB—melanoma	3.6e-06	5.69e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KRAS—melanoma	3.57e-06	5.64e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT1—melanoma	3.5e-06	5.54e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTEN—melanoma	3.44e-06	5.44e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CA—melanoma	3.29e-06	5.2e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CA—melanoma	3.28e-06	5.18e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTEN—melanoma	3.24e-06	5.13e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CA—melanoma	3.21e-06	5.09e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CG—melanoma	3.2e-06	5.06e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CB—melanoma	3.18e-06	5.03e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—melanoma	3.17e-06	5.02e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—melanoma	3.15e-06	4.98e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARG—melanoma	3.09e-06	4.89e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HRAS—melanoma	3.03e-06	4.8e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—melanoma	2.9e-06	4.59e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CD—melanoma	2.81e-06	4.45e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CA—melanoma	2.78e-06	4.41e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALB—melanoma	2.78e-06	4.39e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTEN—melanoma	2.74e-06	4.34e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKT1—melanoma	2.69e-06	4.25e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT1—melanoma	2.68e-06	4.24e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKT1—melanoma	2.63e-06	4.16e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CB—melanoma	2.45e-06	3.88e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—melanoma	2.43e-06	3.84e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CA—melanoma	2.43e-06	3.84e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CA—melanoma	2.29e-06	3.62e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKT1—melanoma	2.27e-06	3.6e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTEN—melanoma	2.12e-06	3.35e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKT1—melanoma	1.98e-06	3.14e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CA—melanoma	1.94e-06	3.06e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKT1—melanoma	1.87e-06	2.95e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKT1—melanoma	1.58e-06	2.5e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CA—melanoma	1.49e-06	2.36e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKT1—melanoma	1.22e-06	1.93e-05	CbGpPWpGaD
